Clinical Trials

NRG-BN013: PHASE III TRIAL OF SINGLE FRACTION STEREOTACTIC RADIOSURGERY (SRS) VERSUS FRACTIONATED SRS (FSRS) FOR INTACT BRAIN METASTASES

ClinicalTrials.gov Identifier

NCT06500455

Principal Investigator

Eva Galvan M.D.

For more information about this study
View Details

About This Study

NRG-BN013 is an unblinded, randomized phase III trial to determine if the time to local failure is significantlylonger with FSRS compared to SRS in patients with intact brain metastasis.